Vascular dysfunction in the pathogenesis of Alzheimer's disease—A review of endothelium-mediated mechanisms and ensuing vicious circles

LY Di Marco, A Venneri, E Farkas, PC Evans… - Neurobiology of …, 2015 - Elsevier
Late-onset dementia is a major health concern in the ageing population. Alzheimer's
disease (AD) accounts for the largest proportion (65–70%) of dementia cases in the older …

[HTML][HTML] Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases

AC Rego, CR Oliveira - Neurochemical research, 2003 - Springer
In recent years we have witnessed a major interest in the study of the role of mitochondria,
not only as ATP producers through oxidative phosphorylation but also as regulators of …

Cerebrovascular and blood–brain barrier impairments in Huntington's disease: potential implications for its pathophysiology

J Drouin‐Ouellet, SJ Sawiak, G Cisbani… - Annals of …, 2015 - Wiley Online Library
Objective Although the underlying cause of Huntington's disease (HD) is well established,
the actual pathophysiological processes involved remain to be fully elucidated. In other …

[HTML][HTML] Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer'sa vascular disorder?

RJ Kelleher, RL Soiza - American journal of cardiovascular disease, 2013 - ncbi.nlm.nih.gov
The etiology of Alzheimer's disease (AD) remains unclear. The emerging view is that
cerebrovascular dysfunction is a feature not only of cerebrovascular diseases, such as …

ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage

A Barzilai, G Rotman, Y Shiloh - DNA repair, 2002 - Elsevier
ATM is one of the sentries at the gate of genome stability. This multifunctional protein kinase
orchestrates the intricate array of cellular responses to DNA double-strand breaks. Absence …

Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β

CS Atwood, ME Obrenovich, T Liu, H Chan… - Brain Research …, 2003 - Elsevier
Although much maligned, the amyloid-β (Aβ) protein has been shown to possess a number
of trophic properties that emanate from the protein's ability to bind Cu, Fe and Zn. Aβ …

Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity

SM Cardoso, I Santana, RH Swerdlow… - Journal of …, 2004 - Wiley Online Library
Alzheimer's disease (AD) brain reveals high rates of oxygen consumption and oxidative
stress, altered antioxidant defences, increased oxidized polyunsaturated fatty acids, and …

Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases

P Grammas, J Martinez, B Miller - Expert reviews in molecular …, 2011 - cambridge.org
Diseases of the central nervous system (CNS) pose a significant health challenge, but
despite their diversity, they share many common features and mechanisms. For example …

Neuroprotective and Neurorescue Effects of a Novel Polymeric Nanoparticle Formulation of Curcumin (NanoCurc) in the Neuronal Cell Culture and Animal Model …

B Ray, S Bisht, A Maitra, A Maitra… - Journal of Alzheimer's …, 2011 - content.iospress.com
Alzheimer's disease (AD) is characterized by deposition of amyloid-ß (Aß) plaques within the
brain parenchyma followed by synaptic loss and neuronal death. Deposited Aß reacts with …

Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35

YG Kaminsky, MW Marlatt, MA Smith… - Experimental neurology, 2010 - Elsevier
Amyloid-β peptide (Aβ) is a central player in the pathogenesis and diagnosis of Alzheimer
disease. It aggregates to form the core of Alzheimer disease-associated plaques found in …